Seven Eight Capital, LP Syneos Health, Inc. Transaction History

Seven Eight Capital, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$46.5 - $79.14 $593,572 - $1.01 Million	12,765 New	12,765 $602,000
Q4 2021 Feb 14, 2022	SELL	$86.01 - $102.89 $653,676 - $781,964	-7,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$84.7 - $96.31 $643,720 - $731,956	7,600 New	7,600 $665,000
Q2 2020 Aug 06, 2020	SELL	$34.32 - $62.43 $264,264 - $480,711	-7,700 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$32.64 - $73.63 $137,740 - $310,718	4,220 Added 121.26%	7,700 $304,000
Q4 2019 Feb 13, 2020	SELL	$48.0 - $59.55 $403,200 - $500,220	-8,400 Reduced 70.71%	3,480 $207,000
Q3 2019 Nov 14, 2019	BUY	$46.64 - $55.39 $554,083 - $658,033	11,880 New	11,880 $632,000
Q2 2019 Aug 12, 2019	SELL	$40.81 - $52.42 $845,215 - $1.09 Million	-20,711 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$36.91 - $55.7 $525,229 - $792,611	-14,230 Reduced 40.73%	20,711 $1.07 Million
Q4 2018 Feb 14, 2019	BUY	$36.49 - $51.72 $1.04 Million - $1.48 Million	28,600 Added 451.03%	34,941 $1.38 Million
Q3 2018 Oct 18, 2018	BUY	$46.5 - $53.55 $294,856 - $339,560	6,341 New	6,341 $327,000

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.